{"name":"Pasithea Therapeutics Corp.","slug":"pasithea-therapeutics-corp","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":486559,"revenueGrowth":3130.4,"grossMargin":0,"rdSpend":7198494,"netIncome":-13904584,"cash":16064719,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"date":"2026-03-30","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: ANNUAL REPORT","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-25","type":"deal","source":"simplywall.st","summary":"Positive Signs As Multiple Insiders Buy Pasithea Therapeutics Stock - simplywall.st","headline":"Positive Signs As Multiple Insiders Buy Pasithea Therapeutics Stock","sentiment":"neutral"},{"date":"2026-02-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPQmQ5U2p4RkZmWWQxU0tWcWxxNHRORkNGRGxSYzFyTlRvUHprMUZNLVBic21JallxR213NVVGc2Q4RFZVYUpjTWlqekYwVXFaOGNzSFk5eDg4YkhxOWozVlNOSXFsY0l5dFUtWFRxaVpJTzBNMUhWclkwRUlydXkxQVEyWjVLcE5QV0pGNFpqamNCZHN1NzJ5bi1LeF9zalBUQ3h1QzVVeWdGX3lLVWNYaTJ4Si0?oc=5","date":"2026-02-18","type":"pipeline","source":"Pharmaceutical Executive","summary":"From Sun Belt Boom to Biotech Hub: Why Southern Florida’s Moment has Arrived - Pharmaceutical Executive","headline":"From Sun Belt Boom to Biotech Hub: Why Southern Florida’s Moment has Arrived","sentiment":"neutral"},{"date":"2026-01-28","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-12-15","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-12-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOZERTTmZBWmpnQklMTHo1ZGFVNzJwQnU3WXF0cy1fWEJ4SHJOVnZlQ2tzYTRYLTlOYmFySzlnQVA5a1h0aFZKNTNVTHM5SHJiZWdrVVhsTFl5YkJ5ZWhNQmIwUHY2ZE1NZmtmMjBuXzVFeS0wSE4tTFpqWlBFWlJ4bFY3UDRLWExRbFBEM0pGMmQ5Wm5mSTZMUmptbTZ2QXdlckpLNVhHOGtKZWsyenJUc2hlTE9RVjM2clpjQnhHQjJOeXFo?oc=5","date":"2025-11-28","type":"pipeline","source":"Stocktwits","summary":"Why Did KTTA Stock Soar A Whopping 43% Today? - Stocktwits","headline":"Why Did KTTA Stock Soar A Whopping 43% Today?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxQWkJqN081SHFkRnh5ajBfWExOQl9Ka0RKWjVrOU5KOHEzRm1iNUJhZEx0bm1XNThHbFVLbGJuR240RHhuODZDM3pRWFZsUjd0YmstVEhBRDAzWlF4WDdqMnducGx6ZG5ubHJvUTNBa3hYc2x3REtrUkFHdGl4alJ5OVZlbFRsRmxqdGNkeTNFYzRBNVlqZFd1T0ZKZ2dHdExyZzJRb253MmFMcjZlcElYOTRfWVBheERsaGtuZW16VjVPTnVmdFdjYWNnWENhMFlfdll0QzJYM3pMREtScklyd2JlbkZ1U1QwMUpSc2k1clIyM2Y2N3ZrNVZxSUI4ZnNRRWoxZkZqczEtQmZCcTVMWEs1c0RhWG51N0RrYW1jVWNMNEY4MUZiNHFQY1NtVWo0eUZPNFYyT1ZITzZv?oc=5","date":"2025-05-15","type":"pipeline","source":"GlobeNewswire","summary":"Neurofibromatosis Type 1 Market Set to Witness Significant - GlobeNewswire","headline":"Neurofibromatosis Type 1 Market Set to Witness Significant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNOXRoTDlyLWdQUkdzZTN1a3lmZmZ6cGIwbzY0NmpXNHBTMVhWZXAyc0l2c2NoV0JXQ1lFS0RZNU83MEJVVWxMZWF2WFh0YmZwWTBJNGU2ZzJDQm9UNHpNbnZuMFlXTVVhbXhtaFZCQWtvd1RmTTBwN0F4TE1WcmlmUEJuVHl1Q0hURkVVRHBqSVR6TXhiNVluakRqTDJpMllFeDk1ZVp4Y2Eyd3VsbTZCTmxGRTU?oc=5","date":"2025-05-07","type":"pipeline","source":"stocktitan.net","summary":"Pasithea Therapeutics Announces Closing of $5 Million Public Offering - stocktitan.net","headline":"Pasithea Therapeutics Announces Closing of $5 Million Public Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5EdnUzeXF6N3dvYmM5UHhZR3psNzFHcEh1dDJfNlFRVUxUdGpQbGFjOXZWS3VLN0MwQURzaE1MZjl5MVZONzFoT3BGaXplNWg5UTZz?oc=5","date":"2025-05-06","type":"pipeline","source":"stocktitan.net","summary":"KTTA Stock Price, News & Analysis | Pasithea Therapeutics - stocktitan.net","headline":"KTTA Stock Price, News & Analysis | Pasithea Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxNYVZGb1d4SlV6bHhTQ0RSVURidk9lekxZR0JyZlM1OEFCcmNBcnpaNGZCZzdybERwZFNjb2VSSjJmWXJpdUMwbWMxZW93ZXY0SV8wUDRBSVRaaFRxeFpPNXFCZ3JqQUpwbEtWdFNEY2lPYURISVF2QmV4aG8zdmw0dlpxV0RFT3VnV29fRmdkdDd3WkVrM1VJaU5rb0J3aHdGbkhGeE0yRFM4clBOQWxGT0JaTFcxS3VlVHZzNHU1YjlhQlEtcG1OUjlzdEp1QjU5RlNBeXNlcHZJLVl6SVBONkdkTQ?oc=5","date":"2024-11-13","type":"pipeline","source":"PR Newswire","summary":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight - PR Newswire","headline":"75+ Key Companies Charting New Frontiers in Multiple Sclerosis Therapeutic Space | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTE1ld05sNGgyN1RFWUhoYWotQzJ6ZElaUXlCeHdIYmpxM21HTzF3aTVmX1l5Tnk4ejRMOUxuWGlCVl9QNE43YmMwVllxU2c3Q1VvMWc?oc=5","date":"2024-09-19","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Telomir Pharmaceuticals, Inc. (TELO) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Telomir Pharmaceuticals, Inc. (TELO) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE9FbF9iQUtwaERTUG1WRU40WHQ2akFqNWdtS3FXdnVYajBzeFg3MVg1aHNpd2d6em5NcUh6LWtZeHgtODNRdEdfc2txTUk5Tk1UOWpKLXZsR21DTjBUWk5VRnlsb1VEZ201RmVSRnBOU1JSSjA2TUNV?oc=5","date":"2023-07-31","type":"pipeline","source":"Fortune","summary":"'We’re in the shakeout stage': The psychedelics boom in healthcare has lost its buzz as some companies struggle to make payroll - Fortune","headline":"'We’re in the shakeout stage': The psychedelics boom in healthcare has lost its buzz as some companies struggle to make ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPbDAyUXlFSzViN05GbWkydHJCMEF4T2pHSGtXQmQtMjZnVWFzT3VNQUQzZVkzeWZ1VWNVV0o2ai15Z2ExZWFna1BKYlQtYjRPcnRBLU1JRUdzUG5ZZ2RxZ2d2RGJ3bFFUQVd4VXJfbDJpUEhvcHN1NW05R1pZZl9Cc0JWWGNfTFJ1QUx6Rk5BVXBYY0ZKb2N4ZGxyT2FaU1NqQXVINVBmQnlfaGM?oc=5","date":"2023-05-08","type":"pipeline","source":"Investing News Network","summary":"Psychedelics Stocks to Watch - Investing News Network","headline":"Psychedelics Stocks to Watch","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":486559,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":486559,"period":"2022-12-31"},{"value":15062,"period":"2021-12-31"},{"value":15062,"period":"2021-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":7198494,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-13904584,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":16064719,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}